201 related articles for article (PubMed ID: 19817821)
1. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy.
Liimatainen S; Peltola M; Sabater L; Fallah M; Kharazmi E; Haapala AM; Dastidar P; Knip M; Saiz A; Peltola J
Epilepsia; 2010 May; 51(5):760-7. PubMed ID: 19817821
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients.
Errichiello L; Perruolo G; Pascarella A; Formisano P; Minetti C; Striano S; Zara F; Striano P
J Neuroimmunol; 2009 Jun; 211(1-2):120-3. PubMed ID: 19428124
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
4. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E;
Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553
[TBL] [Abstract][Full Text] [Related]
5. Serum antibodies in epilepsy and seizure-associated disorders.
McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
[TBL] [Abstract][Full Text] [Related]
6. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
Li X; Yang L; Zhou Z; Huang G; Yan X
Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
[TBL] [Abstract][Full Text] [Related]
7. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.
Petrone A; Suraci C; Capizzi M; Giaccari A; Bosi E; Tiberti C; Cossu E; Pozzilli P; Falorni A; Buzzetti R;
Diabetes Care; 2008 Mar; 31(3):534-8. PubMed ID: 18056891
[TBL] [Abstract][Full Text] [Related]
8. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
Arikan E; Sabuncu T; Ozer EM; Hatemi H
J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
[TBL] [Abstract][Full Text] [Related]
9. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
11. Single-tube test for autoantibodies to glutamic acid decarboxylase and proinsulin as first-line screening for autoimmunity in adult-onset diabetic patients.
Valdez SN; Villalba A; Iacono RF; Poskus E
Clin Immunol; 2004 Dec; 113(3):241-7. PubMed ID: 15507388
[TBL] [Abstract][Full Text] [Related]
12. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
13. Newly-diagnosed pediatric epilepsy is associated with elevated autoantibodies to glutamic acid decarboxylase but not cardiolipin.
Veri K; Uibo O; Talvik T; Talvik I; Metsküla K; Napa A; Vaher U; Õiglane-Šlik E; Rein R; Kolk A; Traat A; Uibo R
Epilepsy Res; 2013 Jul; 105(1-2):86-91. PubMed ID: 23538270
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
[TBL] [Abstract][Full Text] [Related]
16. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
Castleden HA; Shields B; Bingley PJ; Williams AJ; Sampson M; Walker M; Gibson JM; McCarthy MI; Hitman GA; Levy JC; Hattersley AT; Vaidya B; Pearson ER
Diabet Med; 2006 Aug; 23(8):834-8. PubMed ID: 16911619
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
18. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
20. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]